Literature DB >> 18023149

Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis.

Jiajun Shi1, Judith A Badner, Elliot S Gershon, Chunyu Liu.   

Abstract

The G72/G30 gene complex (G72 also known as D-amino acid oxidase activator, DAOA) and its chromosomal region 13q32-34 have been linked and associated with both schizophrenia (SCZ) and bipolar disorder (BP) in multiple studies, including our initial association report on BP. However, the inconsistency of associated variants across studies is obvious. Previous meta-analyses had small data sets. The present meta-analysis combined 18 association articles published before April of 2007. There were 19 independent studies of SCZ, with 4304 cases, 5423 controls, and 1384 families, and four independent studies of BP with 1145 cases, 1829 controls, and 174 families. Of 15 single nucleotide polymorphisms (SNPs) analyzed in the 95-kb G72/G30 gene region, M18/rs947267 and M22/rs778293 showed association with SCZ in Asians, and M24/rs1421292 with SCZ in Europeans. The associations of C allele at M18 and A allele at M22 with SCZ in Asians survived conservative Bonferroni correction for multiple testing for 15 markers and subgroup analysis (adjusted P=0.0000253 for M18; adjusted P=0.009 for M22). No single maker showed evidence of overall association with BP. These results suggest that G72/G30 may influence susceptibility to schizophrenia with weak effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023149      PMCID: PMC2237895          DOI: 10.1016/j.schres.2007.10.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  58 in total

1.  A comparison of methods to detect publication bias in meta-analysis.

Authors:  P Macaskill; S D Walter; L Irwig
Journal:  Stat Med       Date:  2001-02-28       Impact factor: 2.373

2.  A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population.

Authors:  Fanggeng Zou; Chao Li; Shiwei Duan; Yonglan Zheng; Niufan Gu; Guoyin Feng; Yangling Xing; Jianguo Shi; Lin He
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

3.  Association of symptoms and executive function in schizophrenia and bipolar disorder.

Authors:  Eugenia Kravariti; Tracy Dixon; Chris Frith; Robin Murray; Philip McGuire
Journal:  Schizophr Res       Date:  2005-05-01       Impact factor: 4.939

Review 4.  Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?

Authors:  Wolfgang Maier; Barbara Höfgen; Astrid Zobel; Marcella Rietschel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

5.  Kraepelin and the differential diagnosis of dementia praecox and manic-depressive insanity.

Authors:  K S Kendler
Journal:  Compr Psychiatry       Date:  1986 Nov-Dec       Impact factor: 3.735

Review 6.  G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis.

Authors:  Sevilla D Detera-Wadleigh; Francis J McMahon
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

7.  The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations.

Authors:  D Hall; J A Gogos; M Karayiorgou
Journal:  Genes Brain Behav       Date:  2004-08       Impact factor: 3.449

8.  Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition.

Authors:  A E Farmer; P McGuffin; I I Gottesman
Journal:  Arch Gen Psychiatry       Date:  1987-07

9.  The G72/G30 gene complex and cognitive abnormalities in schizophrenia.

Authors:  Terry E Goldberg; Richard E Straub; Joseph H Callicott; Ahmad Hariri; Venkata S Mattay; Llewellyn Bigelow; Richard Coppola; Michael F Egan; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2006-03-22       Impact factor: 7.853

10.  Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness.

Authors:  K S Kendler; C C Masterson; K L Davis
Journal:  Br J Psychiatry       Date:  1985-11       Impact factor: 9.319

View more
  36 in total

1.  PKNOX2 is associated with formal thought disorder in schizophrenia: a meta-analysis of two genome-wide association studies.

Authors:  Ke-Sheng Wang; Qunyuan Zhang; Xuefeng Liu; Longyang Wu; Min Zeng
Journal:  J Mol Neurosci       Date:  2012-05-31       Impact factor: 3.444

Review 2.  [Correlations between risk gene variants for schizophrenia and brain structure anomalies].

Authors:  T Nickl-Jockschat; M Rietschel; T Kircher
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

3.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

Review 4.  Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

Authors:  Joseph T Coyle; Alo Basu; Michael Benneyworth; Darrick Balu; Glenn Konopaske
Journal:  Handb Exp Pharmacol       Date:  2012

Review 5.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

Review 6.  Public health significance of neuroticism.

Authors:  Benjamin B Lahey
Journal:  Am Psychol       Date:  2009 May-Jun

7.  G72 influences longitudinal change in frontal lobe volume in schizophrenia.

Authors:  Sarah M Hartz; Beng-Choon Ho; Nancy C Andreasen; Amy Librant; Danielle Rudd; Eric A Epping; Thomas H Wassink
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

Review 8.  The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Authors:  L Verrall; P W J Burnet; J F Betts; P J Harrison
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

9.  Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia.

Authors:  Nicholas J Bass; Susmita R Datta; Andrew McQuillin; Vinay Puri; Khalid Choudhury; Srinivasa Thirumalai; Jacob Lawrence; Digby Quested; Jonathan Pimm; David Curtis; Hugh Md Gurling
Journal:  Behav Brain Funct       Date:  2009-07-08       Impact factor: 3.759

10.  Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.

Authors:  A C Basu; G E Tsai; C-L Ma; J T Ehmsen; A K Mustafa; L Han; Z I Jiang; M A Benneyworth; M P Froimowitz; N Lange; S H Snyder; R Bergeron; J T Coyle
Journal:  Mol Psychiatry       Date:  2008-12-09       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.